• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低剂量多靶标药物治疗,针对多巴胺 D1 和 D3 受体,可减少大鼠觅药行为的线索诱导复吸。

Low-dose polypharmacology targeting dopamine D1 and D3 receptors reduces cue-induced relapse to heroin seeking in rats.

机构信息

Psychology Department, Queens College of the City University of New York, Flushing, New York, USA.

出版信息

Addict Biol. 2021 Jul;26(4):e12988. doi: 10.1111/adb.12988. Epub 2021 Jan 25.

DOI:10.1111/adb.12988
PMID:33496050
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8225548/
Abstract

Chemical compounds that target dopamine (DA) D1 or D3 receptors have shown promise as potential interventions in animal models of cue-induced relapse. However, undesirable side effects or pharmacodynamic profiles have limited the advancement of new compounds in preclinical studies when administered as independent treatments. In this series of experiments, we explored the effects of coadministration of a D1-receptor partial agonist (SKF 77434) and a D3-receptor antagonist (NGB 2904) in heroin-seeking rats within a "conflict" model of abstinence and cue-induced relapse. Rats were first trained to press a lever to self-administer heroin, and drug delivery was paired contingently with cues (e.g., light and pump noise). Self-initiated abstinence was facilitated by applying electrical current to the flooring in front of the levers. Lastly, a relapse response was provoked by noncontingent presentation of conditioned cues. Prior to provocation, rats received a systemic injection of SKF 77434, NGB 2904, or a combination of both compounds to assess treatment effects on lever pressing. Results indicated that the coadministration of low (i.e., independently ineffective) doses of both compounds was more effective in reducing cue-induced relapse to heroin seeking than either compound alone, with some evidence of drug synergism. Follow-up studies indicated that this reduction was not due to motoric impairment nor enhanced sensitivity to the electrified flooring and that this treatment did not significantly affect motivation for food. Implications for the treatment of opiate use disorder and recommendations for further research are discussed.

摘要

靶向多巴胺(DA)D1 或 D3 受体的化合物已显示出作为潜在干预措施在动物模型中的线索诱导复吸的前景。然而,当作为独立治疗药物使用时,不理想的副作用或药效学特征限制了新化合物在临床前研究中的进展。在这一系列实验中,我们在戒断和线索诱导复吸的“冲突”模型中,探讨了 D1 受体部分激动剂(SKF 77434)和 D3 受体拮抗剂(NGB 2904)联合给药对海洛因觅药大鼠的影响。大鼠首先接受训练,按压杠杆自行注射海洛因,药物输送与线索(例如灯光和泵噪声)有条件地配对。通过对杠杆前的地板施加电流,促进了自我发起的禁欲。最后,通过非条件呈现条件线索引发复吸反应。在挑衅之前,大鼠接受系统注射 SKF 77434、NGB 2904 或两种化合物的组合,以评估治疗对杠杆按压的影响。结果表明,联合使用两种低剂量(即单独无效)的化合物更有效地减少线索诱导的海洛因觅药复吸,比单独使用任何一种化合物都更有效,并且有一些药物协同作用的证据。后续研究表明,这种减少不是由于运动障碍,也不是由于对通电地板的敏感性增强,而且这种治疗对食物的动机没有显著影响。讨论了该治疗方法对阿片类药物使用障碍的影响,并提出了进一步研究的建议。

相似文献

1
Low-dose polypharmacology targeting dopamine D1 and D3 receptors reduces cue-induced relapse to heroin seeking in rats.低剂量多靶标药物治疗,针对多巴胺 D1 和 D3 受体,可减少大鼠觅药行为的线索诱导复吸。
Addict Biol. 2021 Jul;26(4):e12988. doi: 10.1111/adb.12988. Epub 2021 Jan 25.
2
Differential effects of blockade of dopamine D1-family receptors in nucleus accumbens core or shell on reinstatement of heroin seeking induced by contextual and discrete cues.伏隔核核心或壳区多巴胺D1家族受体阻断对情境和离散线索诱导的海洛因觅药复燃的不同影响。
J Neurosci. 2007 Nov 14;27(46):12655-63. doi: 10.1523/JNEUROSCI.3926-07.2007.
3
Acute administration of SB-277011A, NGB 2904, or BP 897 inhibits cocaine cue-induced reinstatement of drug-seeking behavior in rats: role of dopamine D3 receptors.急性给予SB-277011A、NGB 2904或BP 897可抑制可卡因线索诱导的大鼠觅药行为复现:多巴胺D3受体的作用
Synapse. 2005 Jul;57(1):17-28. doi: 10.1002/syn.20152.
4
A role for dopamine D1-like receptors in acute food deprivation-induced reinstatement of heroin seeking in rats.多巴胺D1样受体在大鼠急性食物剥夺诱导的海洛因觅求恢复中的作用。
Int J Neuropsychopharmacol. 2009 Mar;12(2):217-26. doi: 10.1017/S1461145708008778. Epub 2008 Apr 14.
5
Effects of systemic or nucleus accumbens-directed dopamine D1 receptor antagonism on sucrose seeking in rats.系统或伏隔核多巴胺 D1 受体拮抗剂对大鼠蔗糖觅药的影响。
Psychopharmacology (Berl). 2011 Jul;216(2):219-33. doi: 10.1007/s00213-011-2210-y. Epub 2011 Feb 12.
6
Cue-induced resumption of heroin and cocaine seeking in rats using a conflict model of abstinence and relapse.使用戒断和复吸冲突模型诱发大鼠重新摄取海洛因和可卡因。
Psychopharmacology (Berl). 2013 Aug;228(4):651-8. doi: 10.1007/s00213-013-3069-x. Epub 2013 Apr 18.
7
Dopamine D1 and D3 receptor interactions in cocaine reward and seeking in rats.多巴胺D1和D3受体在大鼠可卡因奖赏与觅药行为中的相互作用。
Psychopharmacology (Berl). 2016 Dec;233(23-24):3881-3890. doi: 10.1007/s00213-016-4420-9. Epub 2016 Aug 31.
8
The selective dopamine D3 receptor antagonist, SR 21502, reduces cue-induced reinstatement of heroin seeking and heroin conditioned place preference in rats.选择性多巴胺D3受体拮抗剂SR 21502可减少线索诱导的大鼠海洛因觅药行为复现及海洛因条件性位置偏爱。
Drug Alcohol Depend. 2015 Nov 1;156:228-233. doi: 10.1016/j.drugalcdep.2015.09.011. Epub 2015 Sep 25.
9
Antagonism of the dopamine D1-like receptor in mesocorticolimbic nuclei attenuates acute food deprivation-induced reinstatement of heroin seeking in rats.中脑边缘多巴胺 D1 样受体拮抗剂可减弱急性饥饿诱导的大鼠海洛因觅药行为的复燃。
Eur J Neurosci. 2013 Mar;37(6):972-81. doi: 10.1111/ejn.12112. Epub 2013 Jan 16.
10
Chronic restraint stress during withdrawal increases vulnerability to drug priming-induced cocaine seeking via a dopamine D1-like receptor-mediated mechanism.慢性戒断应激在撤退期间增加了通过多巴胺 D1 样受体介导的机制对药物引发可卡因觅药的易感性。
Drug Alcohol Depend. 2018 Jun 1;187:327-334. doi: 10.1016/j.drugalcdep.2018.03.024. Epub 2018 Apr 22.

引用本文的文献

1
Exploring the progression of drug dependence in a methamphetamine self-administration rat model through targeted and non-targeted metabolomics analyses.通过靶向和非靶向代谢组学分析探索 methamphetamine 自我给药大鼠模型中的药物依赖进展。
Sci Rep. 2024 Sep 29;14(1):22543. doi: 10.1038/s41598-024-73247-5.
2
Relapse after electric barrier-induced voluntary abstinence: A review.电刺激诱导自愿戒毒后复吸:综述。
Curr Opin Neurobiol. 2024 Jun;86:102856. doi: 10.1016/j.conb.2024.102856. Epub 2024 Mar 19.
3
End-to-end sequence-structure-function meta-learning predicts genome-wide chemical-protein interactions for dark proteins.端到端序列-结构-功能元学习预测全基因组化学-蛋白质相互作用的暗蛋白质。
PLoS Comput Biol. 2023 Jan 18;19(1):e1010851. doi: 10.1371/journal.pcbi.1010851. eCollection 2023 Jan.
4
Defective synaptic plasticity in a model of Coffin-Lowry syndrome is rescued by simultaneously targeting PKA and MAPK pathways.Coffin-Lowry 综合征模型中的突触可塑性缺陷可通过同时靶向 PKA 和 MAPK 途径得到挽救。
Learn Mem. 2022 Nov 29;29(12):435-446. doi: 10.1101/lm.053625.122. Print 2022 Dec.
5
DNA methyltransferase activity in the basolateral amygdala is critical for reconsolidation of a heroin reward memory.基底外侧杏仁核中的DNA甲基转移酶活性对于海洛因奖赏记忆的重新巩固至关重要。
Front Mol Neurosci. 2022 Sep 13;15:1002139. doi: 10.3389/fnmol.2022.1002139. eCollection 2022.
6
Altered Accumbal Dopamine Terminal Dynamics Following Chronic Heroin Self-Administration.慢性海洛因自我给药后伏隔核多巴胺末梢动力学的改变。
Int J Mol Sci. 2022 Jul 23;23(15):8106. doi: 10.3390/ijms23158106.
7
Animal Models of Drug Relapse and Craving after Voluntary Abstinence: A Review.动物模型在自愿戒断后药物复吸和觅药行为中的研究进展
Pharmacol Rev. 2021 Jul;73(3):1050-1083. doi: 10.1124/pharmrev.120.000191.

本文引用的文献

1
The highly selective dopamine DR antagonist, R-VK4-40 attenuates oxycodone reward and augments analgesia in rodents.高度选择性的多巴胺 DR 拮抗剂 R-VK4-40 可减弱阿片类药物(如羟考酮)的奖赏效应,并增强其镇痛作用。
Neuropharmacology. 2019 Nov 1;158:107597. doi: 10.1016/j.neuropharm.2019.04.003. Epub 2019 Apr 8.
2
Dopamine D1 and D3 receptor modulators restore morphine analgesia and prevent opioid preference in a model of neuropathic pain.多巴胺 D1 和 D3 受体调节剂可恢复吗啡镇痛作用,并预防神经病理性疼痛模型中的阿片类药物偏好。
Neuroscience. 2019 May 15;406:376-388. doi: 10.1016/j.neuroscience.2019.03.034. Epub 2019 Mar 23.
3
Dopamine DR antagonist VK4-116 attenuates oxycodone self-administration and reinstatement without compromising its antinociceptive effects.多巴胺 DR 拮抗剂 VK4-116 可减弱羟考酮的自身给药和复吸,而不影响其镇痛作用。
Neuropsychopharmacology. 2019 Jul;44(8):1415-1424. doi: 10.1038/s41386-018-0284-5. Epub 2018 Nov 27.
4
NIDA's medication development priorities in response to the Opioid Crisis: ten most wanted.美国国家药物滥用研究所应对阿片类药物危机的药物研发重点:十大急需药物。
Neuropsychopharmacology. 2019 Mar;44(4):657-659. doi: 10.1038/s41386-018-0292-5. Epub 2018 Dec 7.
5
Tardive dyskinesia risk with first- and second-generation antipsychotics in comparative randomized controlled trials: a meta-analysis.比较随机对照试验中第一代和第二代抗精神病药物导致迟发性运动障碍的风险:一项荟萃分析。
World Psychiatry. 2018 Oct;17(3):330-340. doi: 10.1002/wps.20579.
6
Risk Factors and Pooled Rate of Prolonged Opioid Use Following Trauma or Surgery: A Systematic Review and Meta-(Regression) Analysis.创伤或手术后长期阿片类药物使用的风险因素和汇总率:系统评价和荟萃(回归)分析。
J Bone Joint Surg Am. 2018 Aug 1;100(15):1332-1340. doi: 10.2106/JBJS.17.01239.
7
(-)-Stepholidine reduces cue-induced reinstatement of cocaine seeking and cocaine self-administration in rats.(-)-石杉碱甲可减少大鼠线索诱导的可卡因觅药行为复发和可卡因自身给药。
Drug Alcohol Depend. 2018 Aug 1;189:49-54. doi: 10.1016/j.drugalcdep.2018.04.030. Epub 2018 May 31.
8
Dopamine D1 and D3 receptor polypharmacology as a potential treatment approach for substance use disorder.多巴胺 D1 和 D3 受体的多药理学作为物质使用障碍的一种潜在治疗方法。
Neurosci Biobehav Rev. 2018 Jun;89:13-28. doi: 10.1016/j.neubiorev.2018.03.020. Epub 2018 Mar 22.
9
Environmental enrichment facilitates cocaine abstinence in an animal conflict model.环境丰富促进动物冲突模型中的可卡因戒除。
Pharmacol Biochem Behav. 2018 Mar;166:35-41. doi: 10.1016/j.pbb.2018.01.006. Epub 2018 Jan 31.
10
The dopamine D3 receptor, a quarter century later.25年后的多巴胺D3受体。
Eur J Neurosci. 2017 Jan;45(1):2-19. doi: 10.1111/ejn.13390. Epub 2016 Oct 3.